Vivanza Biosciences Ltd

Vivanza Biosci. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vivanza Biosciences Ltd

₹ 3.32 -0.30%
24 Dec 9:09 a.m.
vivanzabiosciences.com BSE: 530057
About

Incorporated in 2016, Vivanza Biosciences
Ltd is in the business of Pharmaceutical Products

Key Points

Business Overview:[1]
Vivanza Biosciences Limited is a specialty pharma company focused on commercializing novel and generic pharmaceuticals, developing oral drug delivery systems, and having expertise in complex oral and topical dose forms including highly potent compounds, modified release products & injections

Website BSE
  • Market Cap ₹ 13.3 Cr.
  • Current Price ₹ 3.32
  • High / Low ₹ 11.7 / 3.23
  • Stock P/E 148
  • Book Value ₹ 1.23
  • Dividend Yield 0.00 %
  • ROCE 10.2 %
  • ROE 12.6 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Debtor days have improved from 227 to 151 days.
  • Company's working capital requirements have reduced from 156 days to 77.1 days

Cons

  • Stock is trading at 2.71 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Promoter holding is low: 39.9%
  • Company has a low return on equity of 12.9% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 151 days.
  • Promoter holding has decreased over last 3 years: -7.94%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
2.81 1.52 5.85 2.35 1.35 5.86 8.24 9.23 7.62 6.56 4.42 2.44 3.00
2.77 1.49 5.95 2.23 1.38 5.30 8.23 8.64 7.30 6.27 4.56 2.08 2.89
Operating Profit 0.04 0.03 -0.10 0.12 -0.03 0.56 0.01 0.59 0.32 0.29 -0.14 0.36 0.11
OPM % 1.42% 1.97% -1.71% 5.11% -2.22% 9.56% 0.12% 6.39% 4.20% 4.42% -3.17% 14.75% 3.67%
0.32 0.02 0.00 0.05 0.30 0.01 0.12 0.01 0.05 0.02 -0.03 0.00 0.00
Interest 0.10 0.10 0.10 0.10 0.10 0.11 0.11 0.11 0.11 0.10 0.09 0.09 0.09
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Profit before tax 0.26 -0.05 -0.20 0.07 0.17 0.46 0.02 0.49 0.26 0.21 -0.27 0.27 0.02
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 600.00% 0.00% 0.00% 0.00% 55.56% 0.00% 0.00%
0.26 -0.05 -0.20 0.07 0.17 0.46 -0.10 0.49 0.26 0.21 -0.41 0.27 0.02
EPS in Rs 0.06 -0.01 -0.05 0.02 0.04 0.12 -0.02 0.12 0.06 0.05 -0.10 0.07 0.00
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
0.00 3.46 6.44 2.66 9.56 9.89 10.39 17.81 27.84 16.42
0.06 3.77 5.84 2.68 9.90 9.80 10.45 17.14 26.76 15.80
Operating Profit -0.06 -0.31 0.60 -0.02 -0.34 0.09 -0.06 0.67 1.08 0.62
OPM % -8.96% 9.32% -0.75% -3.56% 0.91% -0.58% 3.76% 3.88% 3.78%
0.00 0.04 0.00 0.00 0.57 0.51 0.83 0.48 0.05 -0.01
Interest 0.00 0.04 0.37 0.42 0.44 0.47 0.43 0.43 0.42 0.37
Depreciation 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01 0.01
Profit before tax -0.06 -0.31 0.23 -0.44 -0.21 0.12 0.33 0.72 0.70 0.23
Tax % 0.00% 0.00% 13.04% 0.00% 0.00% 41.67% 0.00% 16.67% 21.43%
-0.06 -0.31 0.21 -0.44 -0.21 0.08 0.33 0.60 0.55 0.09
EPS in Rs -0.32 -0.08 0.05 -0.11 -0.05 0.02 0.08 0.15 0.14 0.02
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 60%
3 Years: 41%
TTM: -47%
Compounded Profit Growth
10 Years: %
5 Years: 27%
3 Years: 90%
TTM: -92%
Stock Price CAGR
10 Years: 21%
5 Years: 20%
3 Years: -44%
1 Year: -68%
Return on Equity
10 Years: %
5 Years: 8%
3 Years: 13%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 0.19 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00 4.00
Reserves -0.16 -0.47 -0.27 -0.71 -0.92 -0.84 -0.51 0.09 0.64 0.92
0.50 0.90 1.32 1.48 0.39 0.36 5.51 8.00 5.17 6.24
0.11 2.73 5.10 6.33 8.89 4.93 6.56 10.39 9.69 10.80
Total Liabilities 0.64 7.16 10.15 11.10 12.36 8.45 15.56 22.48 19.50 21.96
0.00 2.31 2.31 2.31 2.31 2.32 2.32 2.31 2.34 2.34
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.64 4.85 7.84 8.79 10.05 6.13 13.24 20.17 17.16 19.62
Total Assets 0.64 7.16 10.15 11.10 12.36 8.45 15.56 22.48 19.50 21.96

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
0.00 -2.07 -0.09 0.86 2.98 -3.08 2.47 -0.95 2.04
0.00 1.90 0.00 0.00 0.00 -0.02 0.00 0.00 -0.04
0.00 0.39 -0.55 -0.89 -2.75 2.80 -2.48 1.03 -1.98
Net Cash Flow 0.00 0.23 -0.64 -0.03 0.22 -0.30 -0.01 0.09 0.03

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 266.89 287.35 782.14 249.70 230.66 275.42 255.77 151.30
Inventory Days 215.20 150.49 309.32 38.07 25.93 91.82 54.64 28.27
Days Payable 304.36 319.46 878.47 319.47 153.98 207.06 211.26 115.76
Cash Conversion Cycle 177.72 118.38 212.99 -31.71 102.61 160.18 99.15 63.81
Working Capital Days 388.21 281.12 592.78 116.07 117.36 204.81 184.86 77.09
ROCE % -10.48% 12.66% -0.41% 5.58% 16.88% 12.14% 10.91% 10.23%

Shareholding Pattern

Numbers in percentages

64 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
47.80% 47.80% 47.80% 47.80% 47.80% 47.80% 47.80% 47.29% 44.90% 43.24% 40.05% 39.86%
52.20% 52.20% 52.20% 52.20% 52.20% 52.20% 52.20% 52.70% 55.10% 56.75% 59.95% 60.13%
No. of Shareholders 4,6414,6434,6364,6624,6744,8724,8675,0395,9376,99216,94116,701

Documents

Announcements

Annual reports